A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT06660173 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06660173
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2025-10-06
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.